Related Experiment Videos
Managing board relationships in tough times
Kimberly Commins1, John Render
1Hall, Render, Killian, Heath & Lyman, PSC, Troy, USA. kcommins@hallrender.com
Michigan Health & Hospitals
|July 31, 2003
Summary
Corporate directors face scrutiny due to scandals, leading to regulations like the Sarbanes-Oxley Act. Healthcare directors have additional unique compliance responsibilities within the healthcare industry.
Area of Science:
- Corporate Governance
- Healthcare Management
- Regulatory Compliance
Background:
- Public scandals have intensified scrutiny of corporate directors.
- The Sarbanes-Oxley Act of 2002 established new standards for for-profit corporate board members.
- Corporate responsibility is a universal concern for all board members.
Purpose of the Study:
- To highlight the distinct compliance responsibilities of healthcare organization directors.
- To examine the intersection of corporate governance and healthcare industry-specific regulations.
Main Methods:
- Analysis of corporate governance principles.
- Review of healthcare industry regulations and compliance requirements.
- Examination of the Sarbanes-Oxley Act's impact on corporate boards.
Main Results:
- Directors of healthcare organizations face a dual set of responsibilities: general corporate duties and industry-specific compliance obligations.
- Unique healthcare regulations add complexity to the oversight role of directors in this sector.
- Compliance in healthcare requires adherence to both general corporate law and specialized healthcare statutes.
Conclusions:
- Healthcare directors must navigate a complex regulatory landscape.
- Understanding and meeting unique healthcare compliance requirements is critical for effective corporate governance in the sector.
- The findings underscore the need for specialized knowledge among healthcare board members.